Canadian researchers exploring recent naturalistic psychedelic and subsequent daily illicit opioid consumption suggest that psychedelics may be able to produce detectable reductions in subsequent substance use. What investigators found was that “psychedelic use remained independently associated with a significantly reduced odds of subsequent daily opioid use,” study authors write. That said, “further examination of characteristics and patterns of cannabis use is warranted and may inform more tailored assessments and treatment recommendations,” the study authors added. Of the 3,813 PWUD at baseline, 1,093 people reported they used illicit opioids daily and 229 said they had used psychedelics in the past six months. And a U.S. study this summer showed that states with legal recreational cannabis witnessed a short-term decline in opioid-related emergency department visits.
Canadian researchers exploring recent naturalistic psychedelic and subsequent daily illicit opioid consumption suggest that psychedelics may be able to produce detectable reductions in subsequent substance use.
Investigators make clear not to draw too firm conclusions but suggest their findings dovetail with other similarly promising results.
“While confirmation in other settings is required, these findings align with growing evidence that psychedelic use may be associated with detectable reductions in subsequent substance use, including illicit opioid use,” notes the study, scheduled to be published...
Read the full article @ The Growth Op